Key Facts GPs Should Know About GLP-1 Analogs
Family Medicine Initiative
APRIL 9, 2024
13 Here is some evidence: From 2004-2020, 8,718 GLP-1 analogs-associated tumors were reported to the FDA. Patients with heart failure show less hospital admissions improved symptoms (in correlation to their weight loss). Stopping the medication leads to a rebound effect (½ – ⅔ weight regain after one year).
Let's personalize your content